• Je něco špatně v tomto záznamu ?

Development and evaluation of innovative enteric-coated capsules for colon-specific delivery of hydrophilic biomaterials

N. Fülöpová, K. Brückner, J. Muselík, S. Pavloková, A. Franc

. 2025 ; 668 (-) : 124991. [pub] 20241122

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25002843

OBJECTIVE: This research aims to design and evaluate an enteric-coated hard capsule dosage form for targeted delivery of biological materials, such as FMT (fecal microbiota transplant) or live microbes, to the distal parts of the GIT. The capsules are designed to be internally protected against destruction by hydrophilic filling during passage through the digestive tract. METHODS: Hard gelatin capsules and DRcapsTMcapsules based on HPMC and gellan were used to encapsulate a hydrophilic body temperature-liquefying gelatin hydrogel with caffeine or insoluble iron oxide mixture. Different combinations of polymers were tested for the internal (ethylcellulose, Eudragit® E, and polyvinyl acetate) and external (Eudragit® S, Acryl-EZE®, and cellacefate) coating. The external protects against the acidic gastric environment, while the internal protects against the liquid hydrophilic filling during passage. Coated capsules were evaluated using standard disintegration and modified dissolution methods for delayed-release dosage forms. RESULTS: Combining suitable internal (ethylcellulose 1.0 %) and external (Eudragit® S 20.0 %) coating of DRcapsTM capsules with the wiping and immersion method achieved colonic release times. While most coated capsules met the pharmaceutical requirements for delayed release, one combination stood out. Colonic times were indicated by the dissolution of soluble caffeine (during 120-720 min) measured by the dissolution method, and capsule rupture was indicated by the release of insoluble iron oxide (after 480 min) measured by the disintegration method. This promising result demonstrates the composition's suitability and potential to protect the content until it's released, inspiring hope for the future of colon-targeted delivery systems and its potential for the pharmaceutical and biomedical fields. CONCLUSION: Innovative and easy capsule coatings offer significant potential for targeted drugs, especially FMT water suspension, to the GIT, preferably the colon. The administration method is robust and not considerably affected by the quantity of internal or external coatings. It can be performed in regular laboratories without specialized individual and personalized treatment equipment, making it a practical and feasible method for drug delivery.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002843
003      
CZ-PrNML
005      
20250206103912.0
007      
ta
008      
250121e20241122ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijpharm.2024.124991 $2 doi
035    __
$a (PubMed)39580105
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Fülöpová, Nicole $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Brno 612 00, Czech Republic
245    10
$a Development and evaluation of innovative enteric-coated capsules for colon-specific delivery of hydrophilic biomaterials / $c N. Fülöpová, K. Brückner, J. Muselík, S. Pavloková, A. Franc
520    9_
$a OBJECTIVE: This research aims to design and evaluate an enteric-coated hard capsule dosage form for targeted delivery of biological materials, such as FMT (fecal microbiota transplant) or live microbes, to the distal parts of the GIT. The capsules are designed to be internally protected against destruction by hydrophilic filling during passage through the digestive tract. METHODS: Hard gelatin capsules and DRcapsTMcapsules based on HPMC and gellan were used to encapsulate a hydrophilic body temperature-liquefying gelatin hydrogel with caffeine or insoluble iron oxide mixture. Different combinations of polymers were tested for the internal (ethylcellulose, Eudragit® E, and polyvinyl acetate) and external (Eudragit® S, Acryl-EZE®, and cellacefate) coating. The external protects against the acidic gastric environment, while the internal protects against the liquid hydrophilic filling during passage. Coated capsules were evaluated using standard disintegration and modified dissolution methods for delayed-release dosage forms. RESULTS: Combining suitable internal (ethylcellulose 1.0 %) and external (Eudragit® S 20.0 %) coating of DRcapsTM capsules with the wiping and immersion method achieved colonic release times. While most coated capsules met the pharmaceutical requirements for delayed release, one combination stood out. Colonic times were indicated by the dissolution of soluble caffeine (during 120-720 min) measured by the dissolution method, and capsule rupture was indicated by the release of insoluble iron oxide (after 480 min) measured by the disintegration method. This promising result demonstrates the composition's suitability and potential to protect the content until it's released, inspiring hope for the future of colon-targeted delivery systems and its potential for the pharmaceutical and biomedical fields. CONCLUSION: Innovative and easy capsule coatings offer significant potential for targeted drugs, especially FMT water suspension, to the GIT, preferably the colon. The administration method is robust and not considerably affected by the quantity of internal or external coatings. It can be performed in regular laboratories without specialized individual and personalized treatment equipment, making it a practical and feasible method for drug delivery.
650    12
$a tobolky $7 D002214
650    12
$a kolon $x metabolismus $7 D003106
650    12
$a hydrofobní a hydrofilní interakce $7 D057927
650    12
$a celulosa $x chemie $x analogy a deriváty $7 D002482
650    12
$a lékové transportní systémy $x metody $7 D016503
650    12
$a želatina $x chemie $7 D005780
650    12
$a uvolňování léčiv $7 D065546
650    _2
$a kofein $x chemie $x aplikace a dávkování $7 D002110
650    _2
$a kyseliny polymethakrylové $x chemie $7 D011109
650    _2
$a železité sloučeniny $x chemie $x aplikace a dávkování $7 D005290
650    _2
$a bakteriální polysacharidy $x chemie $7 D011135
650    _2
$a léky s prodlouženým účinkem $x chemie $7 D003692
650    _2
$a biokompatibilní materiály $x chemie $7 D001672
650    _2
$a hydrogely $x chemie $7 D020100
650    _2
$a polymery $x chemie $7 D011108
650    _2
$a polyvinyly $x chemie $7 D011145
650    _2
$a deriváty hypromelózy $x chemie $7 D065347
655    _2
$a časopisecké články $7 D016428
700    1_
$a Brückner, Kateřina $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Brno 612 00, Czech Republic
700    1_
$a Muselík, Jan $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Brno 612 00, Czech Republic
700    1_
$a Pavloková, Sylvie $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Brno 612 00, Czech Republic. Electronic address: pavlokovas@pharm.muni.cz
700    1_
$a Franc, Aleš $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Brno 612 00, Czech Republic
773    0_
$w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 668 (20241122), s. 124991
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39580105 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206103907 $b ABA008
999    __
$a ok $b bmc $g 2262940 $s 1238850
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 668 $c - $d 124991 $e 20241122 $i 1873-3476 $m International journal of pharmaceutics $n Int J Pharm $x MED00002359
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...